Dronedarone vs placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial

Back

ESC Premium Access

Dronedarone vs placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial

Session: Arrhythmias, General ePosters

Topic: Antiarrhythmic Drug Treatment

Speaker: Associate Professor M. Vamos (Szeged, HU)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)

0 follower

100 more presentations in this session

Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes

Speaker: Professor G. Frommeyer (Munster, DE)

Access

Abstract

Slides

Inflammation of conduction tissue in patients with arrhythmic phenotype of myocarditis

Speaker: Doctor A. Frustaci (Rome, IT)

Access

Abstract

Slides

The pleiotropic effect of a deleterious DES mutation in familial atrial fibrillation and the role of PDE4DIP as a genetic modifier for heart block

Speaker: Doctor M. Abou Ziki (New Haven, US)

Access

Abstract

Slides

Gen-editing to model Short QT syndrome type 5 using human-induced pluripotent stem cell-derived cardiomyocytes

Speaker: Mr L. Maywald (Mannheim, DE)

Access

Abstract

Slides

Inducibility of atrial fibrillation is associated with disturbed activation pattern in bachmanns bundle

Speaker: Ms L. van Staveren (Rotterdam, NL)

Access

Abstract

Slides

Access the full session

Arrhythmias, General ePosters

Speakers: Associate Professor M. Vamos, Professor G. Frommeyer, Doctor A. Frustaci, Doctor M. Abou Ziki, Mr L. Maywald...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources